Document:

exv10w9w4

 

EXHIBIT 10.9.4

EMPLOYMENT AGREEMENT

     EMPLOYMENT AGREEMENT (this “Agreement”), dated as of June 26, 2007, by and between Par
Pharmaceutical, Inc., a Delaware corporation (“Par” or “Employer”), and Gerard Martino
(“Executive”).

RECITALS:

     A. WHEREAS, Executive is presently employed in the capacity of Executive Vice President and
Chief Financial Officer; and

     B. WHEREAS, Employer and Executive desire to cancel and replace Executive’s existing
Employment Agreement, dated March 16, 2006, and enter into this Agreement in order for Executive to
assume the position of Executive Vice President and Chief Operating Officer of Par to perform the
duties associated with this position with Employer on the terms and conditions set forth herein.

     In consideration of the mutual promises herein contained, the parties hereto hereby agree as
follows:

     1. Employment.

          1.1. General. Employer hereby employs Executive in the capacity of Executive Vice
President and Chief Operating Officer of Par at the compensation rate and benefits set forth in
Section 2 hereof for the Employment Term (as defined in Section 3.1 hereof). Executive hereby
accepts such employment, subject to the terms and conditions herein contained. In all such
capacity, Executive shall perform and carry out such duties and responsibilities as may be assigned
to him from time to time by the Board and by the Chief Executive Officer of Par reasonably
consistent with Executive’s position and this Agreement, and shall report to the Board and the
Chief Executive Officer of Par.

          1.2. Time Devoted to Position. Executive, during the Employment Term, shall devote
substantially all of his business time, attention and skills to the business and affairs of
Employer.

          1.3. Certifications. Whenever the Chief Executive Officer of Par is required by law,
rule or regulation or requested by any governmental authority or by Par’s auditors to provide
certifications with respect to Par’s financial statements or filings with the Securities and
Exchange Commission or any other governmental authority, Executive shall sign such certifications
as may be reasonably requested by the Chief Executive Officer of Par and/or Employer, with such
exceptions as Executive deems necessary to make such certifications accurate and not misleading.

 

 

     2. Compensation and Benefits.

          2.1. Salary. At all times Executive is employed hereunder, Employer shall pay to
Executive, and Executive shall accept, as full compensation for any and all services rendered and
to be rendered by him during such period to Employer in all capacities, including, but not limited
to, all services that may be rendered by him to any of Employer’s existing subsidiaries, entities
and organizations hereafter formed, organized or acquired by Employer, directly or indirectly
(each, a “Subsidiary” and collectively, the “Subsidiaries”), the following: (i) a base salary at
the annual rate of $470,000 (Four Hundred and Seventy Thousand Dollars), or at such increased rate
as the Board (through its Compensation and Equity Awards Committee), in its sole discretion, may
hereafter from time to time grant to Executive hereof (as so adjusted, the “Base Salary”); and (ii)
any additional bonus and the benefits set forth in Sections 2.2, 2.3 and 2.4 hereof. The Base
Salary shall be payable in accordance with the regular payroll practices of Employer applicable to
senior executives, less such deductions as shall be required to be withheld by applicable law and
regulations or otherwise.

          2.2. Bonus. Subject to Section 3.3 hereof, Executive shall be entitled to an annual
bonus during the Employment Term in such amount (if any) as determined by the Board based on such
performance criteria as it deems appropriate, including, without limitation, Executive’s
performance and Employer’s earnings, financial condition, rate of return on equity and compliance
with regulatory requirements. The target amount of Executive’s annual bonus shall be equal to 50%
(fifty percent) of his Base Salary.

          2.3. Equity Awards. Executive shall be entitled to participate in long-term incentive
plans commensurate with his titles and positions, including, without limitation, stock option,
restricted stock, and similar equity plans of Employer as may be offered from time to time.

          2.4. Executive Benefits.

               2.4.1. Expenses. Employer shall promptly reimburse Executive for expenses he
reasonably incurs in connection with the performance of his duties (including business travel and
entertainment expenses) hereunder, all in accordance with Employer’s policies with respect thereto
as in effect from time to time.

               2.4.2. Employer Plans. Executive shall be entitled to participate in such employee
benefit and welfare plans and programs as Employer may from time to time generally offer or provide
to executive officers of Employer or its Subsidiaries, including, but not limited to, participation
in life insurance, health and accident, medical plans and programs and profit sharing and
retirement plans.

               2.4.3. Vacation. Executive shall be entitled to four (4) weeks of paid vacation per
calendar year, prorated for any partial year.

               2.4.4. Life Insurance. Employer shall obtain (provided, that Executives qualifies on a
non-rated basis) a term life insurance policy, the premiums of which shall be borne by Employer and
the death benefits of which shall be payable to Executive’s estate, or as otherwise directed by
Executive, in the amount of $1 million throughout the Employment Term.

2

 

               2.4.5. Automobile. Employer shall provide Executive with an automobile cash allowance
of one thousand and fifty dollars ($1,050) (gross) per month.

     3. Employment Term; Termination.

          3.1. Employment Term. Executive’s employment hereunder shall commence on the date
hereof and, except as otherwise provided in Section 3.2 hereof, shall continue until the third
(3rd) anniversary of the date of this Agreement (the “Initial Term”). Thereafter, this Agreement
shall automatically be renewed for successive one-year periods commencing on the third (3rd)
anniversary of the date of this Agreement (the Initial Term, together with any such subsequent
employment period(s), being referred to herein as the “Employment Term”), unless Executive or
Employer shall have provided a Notice of Termination (as defined in Section 3.4.2 hereof) in
respect of its or his election not to renew the Employment Term to the other party at least 90 days
prior to such termination. Upon nonrenewal of the Employment Term pursuant to this Section 3.1 or
termination pursuant to Sections 3.2.1 through 3.2.6 hereof, inclusive, Executive shall be released
from any duties hereunder (except as set forth in Section 4 hereof) and the obligations of Employer
to Executive shall be as set forth in Section 3.3 hereof only.

          3.2. Events of Termination. The Employment Term shall terminate upon the occurrence of
any one or more of the following events:

               3.2.1. Death. In the, event of Executive’s death, the Employment Term shall terminate
on the date of his death.

               3.2.2. Without Cause By Executive. Executive may terminate the Employment Term at any
time during such Term for any reason whatsoever by giving a Notice of Termination to Employer. The
Date of Termination pursuant to this Section 3.2.2 shall be thirty (30) days after the Notice of
Termination is given.

               3.2.3. Disability. In the event of Executive’s Disability (as hereinafter defined),
Employer may, at its option, terminate the Employment Term by giving a Notice of Termination to
Executive. The Notice of Termination shall specify the Date of Termination, which date shall not be
earlier than thirty (30) days after the Notice of Termination is given. For purposes of this
Agreement, “Disability” means disability as defined in any long-term disability insurance policy
provided by Employer and insuring Executive, or, in the absence of any such policy, the inability
of Executive for 180 days in any twelve (12) month period to substantially perform his duties
hereunder as a result of a physical or mental illness, all as determined in good faith by the
Board.

               3.2.4. For Cause By Employer. Employer may terminate the Employment Term for “Cause”
based on objective factors determined in good faith by a majority of the Board as set forth in a
Notice of Termination to Executive specifying the reasons for termination and the failure of the
Executive to cure the same within ten (10) days after Employer shall have given the Notice of
Termination; provided, however, that in the event the Board in good faith
determines that the underlying reasons giving rise to such determination cannot be cured, then the
ten (10) day period shall not apply and the Employment Term shall terminate on the date the Notice
of Termination is given. For purposes of this Agreement, “Cause” shall mean (i) Executive’s
conviction of, guilty or no contest plea to, or confession of guilt of, a felony, or other crime
involving moral turpitude; (ii) an act or omission by

3

 

Executive in connection with his employment that constitutes fraud, criminal misconduct,
breach of fiduciary duty, dishonesty, gross negligence, malfeasance, willful misconduct or other
conduct that is materially harmful or detrimental to Employer; (iii) a material breach by Executive
of this Agreement; (iv) continuing failure to perform such duties as are assigned to Executive by
Employer in accordance with this Agreement, other than a failure resulting from a Disability;
(v) Executive’s knowingly taking any action on behalf of Employer or any of its affiliates
without appropriate authority to take such action; (vi) Executive’s knowingly taking any action in
conflict of interest with Employer or any of its affiliates given Executive’s position with
Employer; and/or (vii) the commission of an act of personal dishonesty by Executive that involves
personal profit in connection with Employer.

               3.2.5. Without Cause By Employer. Employer may terminate the Employment Term for any
reason or no reason whatsoever (other than for the reasons set forth elsewhere in this Section 3.2)
by giving a Notice of Termination to Executive. The Notice of Termination shall specify the Date of
Termination, which date shall not be earlier than thirty (30) days after the Notice of Termination
is given or such shorter period if Employer shall pay to Executive that amount of the Base Salary
amount that would have been earned between the thirty (30) day period and such shorter period.

               3.2.6. Employer’s Material Breach. Executive may terminate the Employment Term upon
Employer’s material breach of this Agreement and the continuation of such breach for more than ten
(10) days after written demand for cure of such breach is given to Employer by Executive (which
demand shall identify the manner in which Employer has materially breached this Agreement).
Employer’s material breach of this Agreement shall mean (i) the failure of Employer to make any
payment that it is required to make hereunder to Executive when such payment is due or within two
(2) business days thereafter; (ii) the assignment to Executive, without Executive’s express written
consent, of duties inconsistent with his positions, responsibilities and status with Employer, or a
change in Executive’s reporting responsibilities, titles or offices or any plan, act, scheme or
design to constructively terminate the Executive, or any removal of Executive from his positions
with Employer, except in connection with the termination of the Employment Term by Employer for
Cause, without Cause or Disability or as a result of Executive’s death or voluntary resignation or
by Executive other than pursuant to this Section 3.2.6; (iii) a reduction by Employer in
Executive’s Base Salary; or (iv) a permanent reassignment of Executive’s primary work location,
without the consent of Executive, to a location more than 35 miles from Employer’s executive
offices in Woodcliff Lake, New Jersey.

          3.3. Certain Obligations of Employer Following Termination of the Employment Term.
Following termination of the Employment Term under the circumstances described below, Employer
shall pay to Executive or his estate, as the case may be, the following compensation and provide
the following benefits in full satisfaction and final settlement of any and all claims and demands
that Executive now has or hereafter may have hereunder against Employer. Any and all payments
referenced hereunder are contingent upon Executive’s execution of Employer’s standard form Release
Agreement in effect at the time. In connection with Executive’s receipt of any or all monies and
benefits to be received pursuant to this Section 3.3, Executive shall not have a duty to seek
subsequent employment during the period in which he is receiving severance payments and the
Severance Amount (as defined in Section 3.3.2 hereof) shall not be reduced solely as a result of
Executive’s subsequent employment by an entity other than Employer.

4

 

               3.3.1. For Cause. In the event that the Employment Term is terminated by Employer for
Cause, Employer shall pay to Executive, in a single lump-sum within 30 days of the Date of
Termination, an amount equal to any unpaid but earned Base Salary through the Date of Termination.

               3.3.2. Without Cause by Employer; Material Breach by Employer; Non-Renewal by
Employer. In the event that the Employment Term is terminated by Employer pursuant to Section
3.2.5 hereof or by Executive pursuant to Section 3.2.6 hereof, or is not renewed by Employer
pursuant to Section 3.1 hereof, Employer shall pay to Executive severance in an amount equal to two
(2) times his Base Amount, and Executive shall retain all vested benefits granted pursuant to
Section 2.3 hereof. For purposes hereof, “Base Amount” shall mean the Base Salary in effect at such
applicable time plus, if Executive’s termination is not a result of, in whole or in part,
Executive’s performance in respect of his duties hereunder, the amount of Executive’s last annual
cash bonus pursuant to Section 2.2 hereof. Any payments made in accordance with this Section 3.3.2
shall be made in twenty-four (24) equal monthly installments from the Date of Termination in
accordance with Employer’s regular payroll practices, or, if upon agreement of Executive and
Employer, in a lump sum within 30 days of the Date of Termination, subject to Executive’s continued
compliance with the terms of Section 4 hereof and the execution by Executive of Employer’s standard
form Release Agreement in effect at the time.

               3.3.3. Without Cause By Executive; Election Not to Renew by Executive. In the event
that the Employment Term is terminated by Executive pursuant to Section 3.2.2 hereof or Executive
elects not to renew this Agreement pursuant to Section 3.1 hereof, Employer shall pay to Executive,
in a single lump-sum within 30 days of the Date of Termination, an amount equal to any unpaid but
earned Base Salary through the Date of Termination.

               3.3.4. Death, Disability. In the event that the Employment Term is terminated by
reason of Executive’s death pursuant to Section 3.2.1 hereof or by Employer by reason of
Executive’s Disability pursuant to Section 3.2.3 hereof, Employer shall pay to Executive, subject
to, in the case of Disability, Executive’s continued compliance with Section 4 hereof, the
Severance Amount, less any life insurance and/or disability insurance received by Executive or his
estate pursuant to insurance policies provided by Employer (including pursuant to Section 2.4.4
hereof), payable in accordance with Section 3.3.2 hereof, and Executive shall retain all vested
benefits granted pursuant to Section 2.3 hereof.

               3.3.5. Post-Employment Term Benefits. In the event Executive is terminated pursuant to
Sections 3.2.1 through 3.2.6 hereof, inclusive, or either Employer or Executive elects not to renew
this Agreement pursuant to Section 3.1 hereof, Employer shall reimburse Executive for any unpaid
expenses pursuant to Section 2.4.1 hereof, and Executive will have the opportunity and
responsibility to elect COBRA continuation coverage pursuant to the terms of that law and will thus
be responsible for the execution of the continuation of coverage forms upon termination of his
insurance coverage. Except as provided immediately below, Executive will be responsible for all
COBRA payments. Specifically, if Executive is terminated pursuant to Sections 3.2.3, 3.2.5 or 3.2.6
hereof, or Employer elects not to renew this Agreement pursuant to Section 3.1 hereof, Executive
shall be entitled to participate, at Employer’s expense, in all medical and health plans and
programs of Employer in accordance with COBRA for a period of eighteen (18) months (the “Benefits
Period”), subject to the execution by Executive of Employer’s standard form Release Agreement in
effect at the time and Executive’s continued compliance with the terms of Section 4 hereof;
provided, that Executive’s continued participation is legally possible under the general
terms and provisions of such plans and

5

 

programs; and provided, further, that in the event Executive is entitled to
equal or comparable benefits from a subsequent employer during the Benefits Period, Employer’s
obligation with respect thereto pursuant to this Section 3.3.5 shall end as of such date.

               3.3.6. Equity Awards.

               (a) If, within twelve (12) months following a Change of Control (as defined in Section 3.4.1
hereof) of Employer, the Employment Term is terminated other than for Cause, then Executive (or his
estate) shall have twenty-four (24) months from the date of termination to exercise any vested
equity awards; provided, that the relevant equity award plan remains in effect and such
equity awards shall not have otherwise expired in accordance with the terms thereof. In connection
therewith, Employer agrees to use commercially reasonable efforts to amend Executive’s Equity Award
Agreements if necessary to effectuate the provisions of this Section 3.3.6(a).

               (b) In the event the Employment Term is terminated (i) by Employer pursuant to Section 3.2.5
hereof and the reason for such termination is not related to the performance of Executive in his
duties with respect to Employer, or (ii) by Executive pursuant to Section 3.2.6 hereof, then all
equity awards theretofore granted to Executive shall thereupon vest and Executive shall have
twenty-four (24) months from such date to exercise such options; provided, that the
relevant equity award plan remains in effect and such equity awards shall not have otherwise
expired in accordance with the terms thereof. In connection therewith, Employer agrees to use
commercially reasonable efforts to amend Executive’s Equity Award Agreements if necessary to
effectuate the provisions of this Section 3.3.6(b).

          3.4. Definitions.

               3.4.1. “Change of Control” Defined. A “Change of Control” of Employer means (i) the
approval by the stockholders of Par of the sale, lease, exchange or other transfer (other than
pursuant to internal reorganization) by Par of all or substantially all of its respective assets to
a single purchaser or to a group of associated purchasers; (ii) the first purchase of shares of
equity securities of Par pursuant to a tender offer or exchange offer (other than an offer by Par)
for at least fifteen (15%) percent of the equity securities of Par; (iii) the approval by the
stockholders of Par of an agreement for a merger or consolidation in which Par shall not survive as
an independent, publicly-owned corporation; (iv) the acquisition (including by means of a merger)
by a single purchaser or a group of associated purchasers of securities of Par from either Par or
any third party representing thirty-five (35%) percent or more of the combined voting power of
Par’s then outstanding equity securities in one or a related series of transactions (other than
pursuant to an internal reorganization) or (v) the change of the membership of a majority of the
Board during any period of two (2) consecutive years, unless the election, or the nomination for
election by Par’s stockholders, of each new director was approved by a vote of at least two-thirds
of the directors of the Board still in office who were directors of Par at the beginning of the
period.

               3.4.2. “Notice of Termination” Defined. “Notice of Termination” means a written
notice that indicates the specific termination provision relied upon by Employer or Executive and,
except in the case of termination pursuant to Sections 3.2.1, 3.2.2 or 3.2.5 hereof, that sets
forth in reasonable detail the facts and circumstances claimed to provide a basis for termination
of the Employment Term under the termination provision so indicated.

6

 

               3.4.3. “Date of Termination” Defined. “Date of Termination” means such date as the
Employment Term is expired if not renewed or terminated in accordance with Sections 3.1 or 3.2
hereof.

     4. Confidentiality/Non-Solicitation/Non-Compete.

          4.1. “Confidential Information” Defined. “Confidential Information” means any and all
information (oral or written) relating to Employer or any Subsidiary or any person or entity
controlling, controlled by, or under common control with Employer or any Subsidiary or any of their
respective activities, including, but not limited to, information relating to: technology,
research, test procedures and results, machinery and equipment; manufacturing processes; financial
information; products; identity and description of materials and services used; purchasing; costs;
pricing; customers and prospects; advertising, promotion and marketing; and selling, servicing and
information pertaining to any governmental investigation, except such information which becomes
public, other than as a result of a breach of the provisions of Section 4.2 hereof.

          4.2. Non-disclosure of Confidential Information. Executive shall not at any time
(other than as may be required or appropriate in connection with the performance by him of his
duties hereunder), directly or indirectly, use, communicate, disclose or disseminate any
Confidential Information in any manner whatsoever for the benefit of any person or entity other
than Employer (except as may be required under legal process by subpoena or other court order).

          4.3. Non-Solicitation. Executive shall not, while employed by Employer and for a
period of one (1) year following the Date of Termination, directly or indirectly, hire, offer to
hire, entice away or in any other manner persuade or attempt to persuade any officer, employee,
agent, lessor, lessee, licensor, licensee, customer, prospective customer, or supplier of Employer
or any of its Subsidiaries to discontinue or alter his or its relationship with Employer or any of
its Subsidiaries.

          4.4. Non-Competition. Executive shall not, while employed by Employer and for a period
of one (1) year following the Date of Termination, directly or indirectly provide any services
(whether in the management, sales, marketing, public relations, finance, research, development,
general office, administrative, or other areas) as an employee, agent, stockholder, officer,
director, consultant, advisor, investor, or other representative of Employer’s competitors in the
branded or generic pharmaceutical industry in any state or country in which Employer does or seeks
to do business. Employer’s competitors include any entity, individual, or affiliate of such company
or individual that develops, sells, markets, or distributes any products that compete with or are
the same or similar to those of Employer. However, the restrictions of this paragraph 4.4 shall not
apply if the Employment Term is terminated by Employer pursuant to Section 3.2.5 hereof or by
Executive properly pursuant to Section 3.2.6 hereof; nor shall this paragraph prohibit Executive
from being a passive owner of not more than one percent (1%) of any publicly-traded class of
capital stock of any entity engaged in a competing business.

          4.5. Injunctive Relief. The parties hereby acknowledge and agree that (a) the type,
scope and periods of restrictions imposed in paragraph 4 are necessary, fair and reasonable to
protect Employer’s legitimate business interests and to prevent the inevitable disclosure of
Employer’s Confidential Information; (b) Employer will be irreparably injured in the event of a
breach by Executive of any of his obligations under this Section 4; (c) monetary damages will not
be an adequate remedy for any such breach; (d) Employer will be entitled to injunctive relief, in
addition to any other remedy which

7

 

it may have, in the event of any such breach; and (e) the existence of any claims that
Executive may have against Employer, whether under this Agreement or otherwise, will not be a
defense to the enforcement by Employer of any of its rights under this Section 4.

          4.6. Non-exclusivity and Survival. The covenants of Executive contained in this
Section 4 are in addition to, and not in lieu of, any obligations that Executive may have with
respect to the subject matter hereof, whether by contract, as a matter of law or otherwise, and
such covenants and their enforceability shall survive any termination of the Employment Term by
either party and any investigation made with respect to the breach thereof by Employer at any time.

     5. Miscellaneous Provisions.

          5.1. Severability. If, in any jurisdiction, any term or provision hereof is determined
to be invalid or unenforceable, (a) the remaining terms and provisions hereof shall be unimpaired;
(b) any such invalidity or unenforceability in any jurisdiction shall not invalidate or render
unenforceable such provision in any other jurisdiction; and (c) the invalid or unenforceable term
or provision shall, for purposes of such jurisdiction, be deemed replaced by a term or provision
that is valid and enforceable and that comes closest to expressing the intention of the invalid or
unenforceable term or provision.

          5.2. Execution in Counterparts. This Agreement may be executed in one or more
counterparts, and by the different parties hereto in separate counterparts, each of which shall be
deemed to be an original but all of which taken together shall constitute one and the same
agreement (and all signatures need not appear on any one counterpart), and this Agreement shall
become effective when one or more counterparts has been signed by each of the parties hereto and
delivered to each of the other parties hereto.

          5.3. Notices. All notices, requests, demands and other communications hereunder shall
be in writing and shall be deemed duly given upon receipt when delivered by hand, overnight
delivery or telecopy (with confirmed delivery), or three (3) business days after posting, when
delivered by registered or certified mail or private courier service, postage prepaid, return
receipt requested, as follows:

If to Employer, to:

Par Pharmaceutical, Inc.

300 Tice Boulevard

Woodcliff Lake, New Jersey 07677

Attention: Chairman

Telecopy No. 201-802-4620

Copy to:

Christine A. Amalfe, Esq.

Gibbons, Del Deo, Dolan, Griffinger & Vecchione, P.C.

One Riverfront Plaza

Newark, New Jersey 07102-5496

Telecopy No.: (201) 639-6230

8

 

If to Executive, to:

Gerard Martino

c/o Par Pharmaceutical, Inc.

300 Tice Boulevard

Woodcliff Lake, New Jersey 07677

or to such other address(es) as a party hereto shall have designated by like notice to the other
parties hereto.

          5.4. Amendment. No provision of this Agreement may be modified, amended, waived or
discharged in any manner except by a written instrument executed by both Par and Executive.

          5.5. Entire Agreement. This Agreement and, with respect to Section 3.3.6 hereof,
Executive’s Equity Award Agreements and governing equity award plans constitute the entire
agreement of the parties hereto with respect to the subject matter hereof, and supersede all prior
agreements and understandings of the parties hereto, oral or written, including, but not limited
to, the parties’ Employment Agreement dated March 16, 2006. Executive and Employer hereby agree
that the Employment Agreement dated March 16, 2006, is hereby superseded and of no further force
and effect, and that this Agreement shall be effective as of the date hereof. In the event of any
conflict between Section 3.3.6 hereof and Executive’s Equity Award Agreements and the governing
equity award plans, Section 3.3.6 shall govern.

          5.6. Applicable Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of New Jersey applicable to contracts made and to be wholly performed
therein.

          5.7. Headings. The headings contained herein are for the sole purpose of convenience
of reference, and shall not in any way limit or affect the meaning or interpretation of any of the
terms or provisions of this Agreement.

          5.8. Binding Effect; Successors and Assigns. Executive may not delegate any of his
duties or assign his rights hereunder. This Agreement shall inure to the benefit of, and be binding
upon, the parties hereto and their respective heirs, legal representatives, successors and
permitted assigns. Employer shall require any successor (whether direct or indirect and whether by
purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or
assets of Employer, by an agreement in form and substance reasonably satisfactory to Executive, to
expressly assume and agree to perform this Agreement in the same manner and to the same extent that
Employer would be required to perform if no such succession had taken place.

          5.9. Waiver, etc. The failure of either of the parties hereto to at any time enforce
any of the provisions of this Agreement shall not be deemed or construed to be a waiver of any such
provision, nor to in any way affect the validity of this Agreement or any provision hereof or the
right of either of the parties hereto thereafter to enforce each and every provision of this
Agreement. No waiver of any breach of any of the provisions of this Agreement shall be effective
unless set forth in a written instrument executed by the party against whom or which enforcement of
such waiver is sought,

9

 

and no waiver of any such breach shall be construed or deemed to be a waiver of any other or
subsequent breach.

          5.10. Capacity, etc. Executive and Employer hereby represent and warrant to the other
that, as the case may be: (a) he or it has full power, authority and capacity to execute and
deliver this Agreement, and to perform his or its obligations hereunder; (b) such execution,
delivery and performance shall not (and with the giving of notice or lapse of time or both would
not) result in the breach of any agreements or other obligations to which he or it is a party or he
or it is otherwise bound; and (c) this Agreement is his or its valid and binding obligation in
accordance with its terms.

          5.11. Enforcement; Jurisdiction. If any party institutes legal action to enforce or
interpret the terms and conditions of this Agreement, the prevailing party shall be awarded
reasonable attorneys’ fees at all trial and appellate levels, and the expenses and costs incurred
by such prevailing party in connection therewith. Any legal action, suit or proceeding, in equity
or at law, arising out of or relating to this Agreement shall be instituted exclusively in the
State or Federal courts located in the State of New Jersey, and each party agrees not to assert, by
way of motion, as a defense or otherwise, in any such action, suit or proceeding, any claim that
such party is not subject personally to the jurisdiction of any such court, that the action, suit
or proceeding is brought in an inconvenient forum, that the venue of the action, suit or proceeding
is improper or should be transferred, or that this Agreement or the subject matter hereof may not
be enforced in or by any such court. Each party further irrevocably submits to the jurisdiction of
any such court in any such action, suit or proceeding. Any and all service of process and any other
notice in any such action, suit or proceeding shall be effective against any party if given
personally or by registered or certified mail, return receipt requested or by any other means of
mail that requires a signed receipt, postage prepaid, mailed to such party as herein provided.
Nothing herein contained shall be deemed to affect or limit the right of any party to serve process
in any other manner permitted by applicable law.

          5.12. Arbitration.

          (a) Any dispute under Section 3 hereof, including, but not limited to, the determination by
the Board of a termination for Cause pursuant to Section 3.2.4 hereof, or in respect of the breach
thereof shall be settled by arbitration in New Jersey. The arbitration shall be accomplished in the
following manner. Either party may serve upon the other party written demand that the dispute,
specifying the nature thereof, shall be submitted to arbitration. Within ten (10) days after such
demand is given in accordance with Section 5.3 hereof, each of the parties shall designate an
arbitrator and provide written notice of such appointment upon the other party. If either party
fails within the specified time to appoint such arbitrator, the other party shall be entitled to
appoint both arbitrators. The two (2) arbitrators so appointed shall appoint a third arbitrator. If
the two arbitrators appointed fail to agree upon a third arbitrator within ten (10) days after
their appointment, then an application may be made by either party hereto, upon written notice to
the other party, to the American Arbitration Association (the “AAA”), or any successor thereto, or
if the AAA or its successor fails to appoint a third arbitrator within ten (10) days after such
request, then either party may apply, with written notice to the other, to the Superior Court of
New Jersey, Bergen County, for the appointment of a third arbitrator, and any such appointment so
made shall be binding upon both parties hereto.

          (b) The decision of the arbitrators shall be final and binding upon the parties. The party
against whom the award is rendered (the “non-prevailing party”) shall pay all fees and expenses
incurred by the prevailing party in connection with the arbitration (including fees and
disbursements of

10

 

the prevailing party’s counsel), as well as the expenses of the arbitration proceeding. The
arbitrators shall determine in their decision and award which of the parties is the prevailing
party, which is the non-prevailing party, the amount of the fees and expenses of the prevailing
party and the amount of the arbitration expenses. The arbitration shall be conducted, to the extent
consistent with this Section 5.12, in accordance with the then prevailing rules of commercial
arbitration of the AAA or its successor. The arbitrators shall have the right to retain and consult
experts and competent authorities skilled in the matters under arbitration, but all consultations
shall be made in the presence of both parties, who shall have the full right to cross-examine the
experts and authorities. The arbitrators shall render their award, upon the concurrence of at least
two of their number, not later than thirty (30) days after the appointment of the third arbitrator.
The decision and award shall be in writing, and counterpart copies shall be delivered to each of
the parties. In rendering an award, the arbitrators shall have no power to modify any of the
provisions of this Agreement, and the jurisdiction of the arbitrators is expressly limited
accordingly. Judgment may be entered on the award of the arbitrators and may be enforced in any
court having jurisdiction.

[SIGNATURE PAGE FOLLOWS]

11

 

     IN WITNESS WHEREOF, this Agreement has been executed and delivered by the parties hereto as of
the date first above written.

	 	 	 	 	 
	 	PAR PHARMACEUTICAL, INC.

 	 
	 	By:  	/s/ Patrick LePore
 	 
	 	 	Name:  	Patrick LePore 	 
	 	 	Title:  	President and Chief Executive Officer 	 
	 
	 	 	 
	 	                                          /s/ Gerard Martino
 	 
	 	Gerard Martino 	 
	 	 	 
	 

12exv10w9w11

 

EXHIBIT 10.9.11

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

SEPARATION AND RELEASE AGREEMENT

     This Separation and Release Agreement (“Agreement”) is made by and between PAR PHARMACEUTICAL
COMPANIES, INC., and PAR PHARMACEUTICAL, INC. (collectively referred to as “THE COMPANY”), and
SCOTT L. TARRIFF (“EMPLOYEE”), a specified employee of THE COMPANY. The Effective Date of this
Agreement shall be as set forth in Section 8 herein.

RECITALS

     A. For purposes of this Agreement, “THE COMPANY” means PAR PHARMACEUTICAL COMPANIES, INC., and
PAR PHARMACEUTICAL, INC., and each and any of their parent and subsidiary corporations, affiliates,
departments, divisions, and/or joint ventures.

     B. EMPLOYEE has been employed by THE COMPANY as President and Chief Executive Officer, Par
Pharmaceutical Companies, Inc., and as President and Chief Executive Officer, Par Pharmaceutical,
Inc.

     C. As a result of EMPLOYEE’s separation from THE COMPANY, and to fully and finally resolve all
issues concerning EMPLOYEE’s employment relationship with THE COMPANY, and to reiterate certain
terms contained in EMPLOYEE’s Employment Agreement dated February 9, 2004, THE COMPANY and EMPLOYEE
have decided to enter into this Agreement.

     For and in consideration of the mutual promises and covenants in this Agreement, and for other
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the
parties agree as follows:

OPERATIVE PROVISIONS

          1. Separation of Employment. THE COMPANY and EMPLOYEE agree that EMPLOYEE shall
separate from THE COMPANY effective at the end of business on October 31, 2006 (“Separation Date”),
such separation of employment with THE COMPANY occurring pursuant to Section 3.2.5 of that certain
Employment Agreement dated as of February 9, 2004 by and between the parties (“Employment
Agreement”).

          2. Pay, Benefits and Stock Options Upon Separation.

               (a) Separation Pay. In accordance with the Employment Agreement EMPLOYEE is, on
account of his separation from THE COMPANY, entitled to severance pay in the amount of one million
two hundred eighty four thousand two hundred twenty eight dollars ($1,284,228.00), payable in six
(6) equal installments beginning in the seventh (7th) month after

 

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

the Separation Date and continuing for six (6) months thereafter. The aforementioned payments
shall be subject to all appropriate federal and state withholding and employment taxes. EMPLOYEE
hereby agrees that he is entitled to no other payment from COMPANY as the result of his separation
or during the aforementioned period.

               (b) Benefits/Termination. In accordance with Section 3.3.5 of the Employment
Agreement, on account of EMPLOYEE’s separation from THE COMPANY, THE COMPANY shall, for a two (2)
year period from the Separation Date, maintain in effect for EMPLOYEE coverage under THE COMPANY’S
life insurance, medical, health, accident, and disability plans and programs in which EMPLOYEE was
entitled to participate immediately prior to the Separation; provided, that such benefits shall
immediately terminate in the event EMPLOYEE becomes eligible for coverage by a subsequent employer
prior to the expiration of the two (2) year period. Following the termination of the two (2) year
period, if EMPLOYEE is not eligible for coverage under another employer’s benefit program, EMPLOYEE
will have the opportunity to elect continuation coverage pursuant to COBRA and will thus be
responsible for the execution of the COBRA continuation of coverage forms. All other benefits and
allowances, except those in which EMPLOYEE has vested rights under the terms of an employee benefit
plan, terminate as of the Separation Date. Notwithstanding the foregoing, THE COMPANY shall pay
EMPLOYEE a one-time Executive Heath Care allowance in the amount of five thousand dollars
($5,000.00) within ten (10) days of execution of this Agreement.

(c) Stock Options.

i. The parties agree that as of September 16, 2003, EMPLOYEE was granted
options for seven hundred ninety five thousand (795,000) shares of THE
COMPANY’s common stock. In accordance with the Employment Agreement, these
options shall be exercisable pursuant to their normal vesting schedules and
at the exercise price related to the respective option grants. EMPLOYEE’S
exercise of such options is governed by Section 3.3.6(a) of the Employment
Agreement as well as the terms of the applicable plan, referenced in the
Employment Agreement.

ii. The parties agree that since September 16, 2003 EMPLOYEE has been
granted options for three hundred thirty thousand six hundred thirty three
(330,633) shares of THE COMPANY’s common stock. Any such unvested options
shall vest as of the Effective Date. EMPLOYEE shall have twenty-four (24)
months from such date to exercise all options, at the exercise price related
to the respective option grants, provided that the relevant stock option
plan remains in effect and such options have not otherwise expired.

iii. The parties agree that EMPLOYEE has been granted forty seven thousand
four hundred sixty one (47,461) shares of THE COMPANY’s restricted stock.
Any unvested shares of restricted stock shall vest as of the date of
EMPLOYEE’s execution of this Agreement.

2

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

               (d) In accordance with the Employment Agreement, the payments and benefits contained in this
Section 2 are contingent upon EMPLOYEE’s continued compliance with Section 4 and 5 of the
Employment Agreement, as referenced in Sections 10 and 11 herein.

          3. Earned Salary.

               (a) Accrued Unused Leave. THE COMPANY shall, on the Separation Date, pay EMPLOYEE for
his unused vacation and personal days, which THE COMPANY and EMPLOYEE agree total five hundred
twenty four (524) hours.

               (b) EMPLOYEE acknowledges and agrees that he has been paid in full for all work performed, and
is entitled to no further payments or bonuses from THE COMPANY whatsoever for services rendered or
any other reason, except as set forth herein.

          4. Consideration.

               (a) No Disparagement. THE COMPANY agrees to refrain from any publication or any type
of communication, oral or written, of a defamatory or disparaging statement pertaining to EMPLOYEE.
Nothing in this Section shall be construed as prohibiting THE COMPANY from making any disclosures
as required by law or statute, including the release of such information as is required to be
disclosed by THE COMPANY in connection with any legal proceeding, filing with the Securities and
Exchange Commission (“SEC”) under the Securities Exchange Act of 1934, or as otherwise required by
law.

               (b) Sufficiency of Consideration. No Admission of Liability. The parties agree that
the consideration paid to EMPLOYEE is good and sufficient consideration for this Agreement, to the
extent it imposes upon EMPLOYEE obligations in addition to those contained in the Employment
Agreement. The parties further agree that these amounts are greater than what EMPLOYEE is entitled
to receive under THE COMPANY’s policies, any other verbal or written agreement between the parties,
including but not limited to the Employment Agreement, and applicable law. EMPLOYEE acknowledges
that neither this Agreement, nor payment of any consideration pursuant to this Agreement, shall be
taken or construed to be an admission or concession of any kind with respect to alleged liability
or alleged wrongdoing by THE COMPANY.

          5. Indemnification and Advancement of Expenses. THE COMPANY acknowledges that it will
comply with the indemnification and advancement of expenses covenants contained in Sections 5.1,
5.2, 5.3 and 5.4 of THE COMPANY’s Bylaws and that EMPLOYEE does not waive his rights to such
indemnification.

          6. General Release and Waiver of Claims. Solely in connection with EMPLOYEE’s
employment relationship with THE COMPANY and in accordance with Section 3.3 of the Employment
Agreement, and in consideration of the additional promises and covenants made by THE COMPANY in
this Agreement, EMPLOYEE hereby knowingly and voluntarily compromises, settles and releases THE
COMPANY from any and all past, present, or

3

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

future claims, demands, obligations, or causes of action, whether based on tort, contract,
statutory or other theories of recovery for anything that has occurred up to and including the date
of EMPLOYEE’s execution of this Agreement. The released claims include those EMPLOYEE may have or
has against THE COMPANY, or which may later accrue to or be acquired by EMPLOYEE against THE
COMPANY and its predecessors, successors in interest, assigns, parent and subsidiary organizations,
affiliates, and partners, and its past, present, and future officers, directors, shareholders,
agents, and employees, and their heirs and assigns. EMPLOYEE specifically agrees to release and
waive all claims for wrongful termination and any claim for retaliation or discrimination in
employment under federal or state law or regulation including, but not limited to, discrimination
based on age, sex, race, disability, handicap, national origin or any claims under Title VII of the
Civil Rights Act of 1964, the Age Discrimination in Employment Act of 1967, as amended by the Older
Workers’ Benefits Protection Act (ADEA), the Americans with Disabilities Act of 1990 (ADA), the New
Jersey Law Against Discrimination (LAD), the Consolidated Omnibus Budget Reconciliation Act
(COBRA), the Employee Retirement Income Security Act (ERISA), the Immigration Reform and Control
Act (IRCA), the Fair Labor Standards Act (FLSA), the Conscientious Employee Protection Act (CEPA),
the Family Medical Leave Act (FMLA), the New Jersey Family Leave Act (NJFLA) and the New Jersey
wage and hour law. The release of claims agreed to herein specifically excludes (i) any claims
relating to a breach of this Agreement, and (ii) any counterclaims that are not based on
allegations regarding EMPLOYEE’s employment by THE COMPANY or separation from THE COMPANY that
EMPLOYEE might assert if THE COMPANY were to sue EMPLOYEE.

          7. Covenant Not to Sue.

               (a) Each party represents and agrees that such party has not filed any lawsuits or
arbitrations against the other party, or filed or caused to be filed any charges or complaints
against the other party with any municipal, state or federal agency charged with the enforcement of
any law or any self-regulatory organization.

               (b) THE COMPANY represents that it is currently not aware of any basis for any cause of action
against EMPLOYEE relative to any matter that involved THE COMPANY and that occurred up to and
including the date of THE COMPANY’s execution of this Agreement, except for those which have
already been asserted in the pending shareholder litigation.

               (c) EMPLOYEE agrees, consistent with the EEOC Enforcement Guidance or Non-Waivable Employee
Rights Under EEOC-Enforced Statutes dated April 11, 1997, and to the fullest extent permitted by
laws, not to sue or file a charge, complaint, grievance or demand for arbitration against THE
COMPANY in any claim, arbitration, suit, action, investigation or other proceeding of any kind
which relates to any matter that involved THE COMPANY, and that occurred up to and including the
date of EMPLOYEE’s execution of this Agreement, other than those non-employment-related
counterclaims that EMPLOYEE might assert against THE COMPANY if THE COMPANY were to sue EMPLOYEE,
and unless required to do so by court order, subpoena or other directive by a court, administrative
agency,

4

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

arbitration panel or legislative body, or unless required to enforce this Agreement. Nothing
in this Agreement shall prevent EMPLOYEE from (i) commencing an action or proceeding to enforce
this Agreement, or (ii) exercising EMPLOYEE’s right under the Older Workers Benefit Protection Act
of 1990 to challenge the validity of EMPLOYEE’s waiver of ADEA claims set forth in this Agreement.

          8. Consideration and Revocation Periods: Effective Date. EMPLOYEE also understands
and acknowledges that the ADEA requires THE COMPANY to provide EMPLOYEE with at least twenty one
(21) calendar days to consider this Agreement (“Consideration Period”) prior to its execution.
EMPLOYEE also understands that he is entitled to revoke this Agreement at any time during the seven
(7) days following EMPLOYEE’s execution of this Agreement (“Revocation Period”) by notifying THE
COMPANY in writing of his revocation. This Agreement shall become effective on the day after the
seven-day Revocation Period has expired unless timely notice of EMPLOYEE’s revocation has been
delivered to THE COMPANY (the “Effective Date”).

          9. Return of Company Property. On his Separation Date, and in accordance with Section
5.2 of the Employment Agreement, EMPLOYEE agrees forthwith to deliver to THE COMPANY all of THE
COMPANY’s property in his possession or under his custody and control, including but not limited to
all keys, and tangible items, notebooks, documents, records and other data relating to research or
experiments conducted by any person relating to the products, formulas, formulations, processes or
methods of manufacture of THE COMPANY, and to its customers and pricing of products.

          10. Confidential Information. EMPLOYEE acknowledges that during EMPLOYEE’s employment
with THE COMPANY, EMPLOYEE has had access to Confidential Information (as defined in Section 4.1 -
4.4 of the Employment Agreement). In accordance with the covenants contained in Sections 4.1 and
4.2 of the Employment Agreement, EMPLOYEE shall not at any time (other than as may be required in
connection with the performance by him of any remaining duties or obligations under the Employment
Agreement), directly or indirectly, use, communicate, disclose or disseminate any Confidential
Information in any manner whatsoever (except as may be required under legal process by subpoena or
other court order).

          11. Covenants Not to Solicit. As EMPLOYEE acknowledged in Sections 4.8 and 4.9 of the
Employment Agreement, EMPLOYEE shall be restricted in regard to his post-employment business
undertakings.

               (a) Covenant Not To Solicit Suppliers and Others. EMPLOYEE shall not, for a period of
one (1) year following September 28, 2006, the date on which THE COMPANY provided him with notice
of termination pursuant to the Employment Agreement, directly or indirectly solicit or divert (or
seek to divert) or entice away, for the benefit of EMPLOYEE or any other person or entity, or cause
(or attempt to cause) or persuade in any manner to cease doing business with THE COMPANY or reduce
its level of business with THE COMPANY, any Third Party Relationship, client, supplier, vendor,
contractor, business partner, licensee, licensor, agent or investor, or supplier of source
materials or finished goods, product

5

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

lines or research, who was doing business with THE COMPANY at any time within twelve (12)
months prior to the Separation Date, or who was actively engaged in discussions in contemplation of
any such business relationship during such period. During the above-referenced one year period,
EMPLOYEE may not accept business from any of the above persons or entities where doing so would
have the effect of diverting THE COMPANY’s existing business or would have the effect of reducing
its existing level of business with such entities.

               (b) Covenant Not To Hire or Solicit Employees. In accordance with Section 4.9 of the
Employment Agreement, except with the express written permission of THE COMPANY, EMPLOYEE shall
not, for a period of two (2) years following the Separation Date, directly or indirectly hire,
retain or engage, or offer to hire, retain or engage, or solicit for employment or other retention
or engagement of services, or otherwise induce to leave THE COMPANY, for the benefit of EMPLOYEE or
any other person or entity, any employee or consultant who is then employed by or engaged by THE
COMPANY or was so employed or engaged as of the Separation Date. This Section 11(b) shall not be
construed as prohibiting EMPLOYEE from working with Michael Graves, former President of THE
COMPANY’s Generic Products Division, during the two-year period specified herein.

               (c) The restrictive covenant contained in Section 11(a) of this Agreement and Section 4.8 of
the Employment Agreement is understood by the parties to limit EMPLOYEE from only those activities
that would have the effect of diverting THE COMPANY’s business, diverting THE COMPANY’s business
opportunities with current business partners, or reducing THE COMPANY’s existing level of business
with those entities referenced in the above Section 11(a). To the extent EMPLOYEE desires to sell
products that do not divert THE COMPANY’s business, divert THE COMPANY’s business opportunities
with current business partners, or reduce THE COMPANY’s existing level of business with those
entities referenced in the above Section 11(a), he is specifically permitted to do so with existing
Par customers, including pharmaceutical wholesalers or chains. *** But, even with regard to those entities, EMPLOYEE is not permitted to solicit
business opportunities on products which THE COMPANY currently sells or develops. THE COMPANY
hereby agrees to review, on a good faith basis, any potential revisions to the list of entities
contained herein. THE COMPANY further agrees that consent to such potential revisions shall not be
unreasonably withheld.

               (d) For avoidance of doubt, mere communication or socialization with THE COMPANY’s business
partners shall not be construed as soliciting.

               (e) The restrictive covenants contained in this Section 11 shall not be interpreted to prevent
EMPLOYEE from utilizing non-pharmaceutical-product-based business service providers of THE COMPANY,
such as attorneys, accountants, and consultants (e.g., Lachman); provided, that nothing in this
agreement shall operate as a waiver by THE

6

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

COMPANY of any conflict or confidentiality obligations of such business service provider to
THE COMPANY. THE COMPANY hereby agrees to review, on a good faith basis, any potential revisions
to the business provider service list contained herein.

          12. Confidentiality. EMPLOYEE agrees to keep both the existence and the terms of this
Agreement completely confidential, except that EMPLOYEE may discuss this Agreement with EMPLOYEE’s
attorney, accountant, or other professional person who may assist EMPLOYEE in evaluating,
reviewing, or negotiating this Agreement, and as otherwise permitted or required under applicable
law. EMPLOYEE understands and agrees that his disclosure of the terms of this Agreement contrary to
the terms set forth herein will constitute a breach of this Agreement.

          13. No Disparagement. EMPLOYEE agrees to refrain from any publication or any type of
communication, oral or written, of a defamatory or disparaging statement pertaining to THE COMPANY,
its past, present and future officers, agents, directors, supervisors, employees or
representatives. Nothing in this Section shall be construed as prohibiting EMPLOYEE from making
any disclosures as required by law or statute, including the release of such information as is
required to be disclosed by EMPLOYEE in connection with any legal proceeding, or as otherwise
required by law.

          14. Technology, Products and Inventions. EMPLOYEE shall comply with Sections 4.3 and
4.14 of the Employment Agreement with regard to Intellectual Property, research and development,
and the like, as well as copyright and property rights thereto.

          15. Disclosure of Information. EMPLOYEE represents and warrants that he is not aware
of any material non-public information concerning THE COMPANY, its business or its affiliates that
he has not disclosed to the Board of Directors of THE COMPANY prior to the date of this Agreement
or that is required to be disclosed by THE COMPANY in its filings under the Securities Exchange Act
of 1934 with the Securities and Exchange Commission (“SEC”) and that has not been so disclosed.

          16. Cooperation. In accordance with Section 5.1 of the Employment Agreement, EMPLOYEE
hereby agrees that:

               (a) EMPLOYEE will make himself reasonably available to THE COMPANY either by telephone or, if
THE COMPANY believes necessary, in person upon reasonable notice, to assist THE COMPANY in
connection with any matter relating to services performed by him on behalf of THE COMPANY prior to
the Separation Date.

               (b) EMPLOYEE further agrees that he will cooperate fully with THE COMPANY in relation to any
investigation or hearing with the SEC or any other governmental agency, as well as in the defense
or prosecution of any claims or actions now in existence, including but not limited to ongoing
commercial litigation matters, shareholder derivative actions, and class action law suits, or which
may be brought or threatened in the future against or on behalf of THE COMPANY, its directors,
shareholders, officers, or employees.

7

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

               (c) EMPLOYEE will cooperate in connection with such claims or actions referred to in Paragraph
15(b) above including, without limitation, his being available to meet with THE COMPANY to prepare
for any proceeding (including depositions, fact-findings, arbitrations or trials), to provide
affidavits, to assist with any audit, inspection, proceeding or other inquiry, and to act as a
witness in connection with any litigation or other legal proceeding affecting THE COMPANY.

               (d) EMPLOYEE further agrees that should he be contacted (directly or indirectly) by any
individual or any person representing an individual or entity that is or may be legally or
competitively adverse to THE COMPANY in connection with any claims or legal proceedings, he will
promptly notify THE COMPANY of that fact in writing, but in no event later than the next business
day, or immediately if he already has been so contacted. Such notification shall include a
reasonable description of the content of the communication with the legally or competitively
adverse individual or entity.

               (e) In accordance with the Employment Agreement, THE COMPANY shall reimburse EMPLOYEE for any
reasonable expenses incurred by EMPLOYEE in connection with the cooperation obligations set forth
herein, including all legal fees of counsel selected by EMPLOYEE to represent him in any such
proceeding. In addition to the payment of EMPLOYEE’s expenses, THE COMPANY shall pay the EMPLOYEE
a reasonable per diem fee of two thousand three hundred and fifty dollars ($2,350.00) for each day
for which THE COMPANY requests that EMPLOYEE provide such assistance, which shall be pro-rated as
necessary for each partial day.

               (f) Notwithstanding the provisions herein, EMPLOYEE acknowledges that his cooperation
obligation requires him to participate truthfully and accurately in all matters contemplated under
Section 16.

          17. Injunctive Relief. EMPLOYEE acknowledges that his failure to abide by Sections 10
and 11 of this Agreement, and their counterparts in the Employment Agreement (as well as any other
paragraph in the Employment Agreement which is the subject of Paragraph 5.3 therein), will result
in immediate and irreparable damage to THE COMPANY and will entitle THE COMPANY to injunctive
relief from a court having appropriate jurisdiction.

          18. Representation by Attorney. EMPLOYEE acknowledges that he has been given the
opportunity to be represented by independent counsel in reviewing this Agreement, and that EMPLOYEE
understands the provisions of this Agreement and knowingly and voluntarily agrees to be bound by
them.

          19. No Reliance Upon Representations. EMPLOYEE hereby represents and acknowledges
that in executing this Agreement, EMPLOYEE does not rely and has not relied upon any representation
or statement made by THE COMPANY or by any of THE COMPANY’s past or present agents,
representatives, employees or attorneys with regard to the subject matter, basis or effect of this
Agreement other than as set forth in this Agreement.

8

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

          20. Tax Advice. 

               (a) THE COMPANY makes no representations regarding the federal or state tax consequences of
the payments or benefits referred to above and provided for herein, and shall not be responsible
for any tax liability, interest or penalty including but not limited to those which may arise under
Internal Revenue Service Code Section 409A, incurred by EMPLOYEE which in any way arises out of or
is related to said payments or benefits. With the exception of the regular payroll deductions for
federal and state withholding and employment taxes, EMPLOYEE agrees that it shall be his sole
responsibility to pay any amount that may be due and owing as federal or state taxes, interest and
penalties, including but not limited to those which may arise under Internal Revenue Service Code
Section 409A, arising out of the payments or benefits provided for herein.

               (b) EMPLOYEE agrees and understands that he is not relying upon THE COMPANY or its counsel for
any tax advice regarding the tax treatment of the payments made or benefits received pursuant to
this Agreement, and EMPLOYEE agrees that he is responsible for determining the tax consequences of
all such payments and benefits hereunder, including but not limited to those which may arise under
Internal Revenue Service Code Section 409A, and for paying taxes, if any, that he may owe with
respect to such payments or benefits.

               (c) EMPLOYEE further agrees to (i) hold harmless THE COMPANY and its attorneys against, and
indemnify THE COMPANY and its attorneys for, any and all losses and/or damages arising from claims
by the Internal Revenue Service (“IRS”), or any other taxing authority or other governmental agency
(whether federal, state or local), which may be made against THE COMPANY and its attorneys arising
out of or relating to the payments or benefits hereunder and (ii) reimburse THE COMPANY and its
attorneys for any resulting payment, including without limitation, all penalties and interest
payable to the IRS, or any other taxing authority or governmental agency.

               (d) EMPLOYEE and THE COMPANY further agree that they and their attorneys will give mutual
notice of any such claims. EMPLOYEE agrees that he will cooperate in the defense of such claim.
In any action commenced against EMPLOYEE to enforce the provisions of this paragraph, THE COMPANY
and its attorneys shall be entitled to recover their attorneys’ fees, costs, disbursements, and the
like incurred in prosecuting the action.

          21. Employment Agreement. The parties acknowledge and agree that all pertinent terms
of the Employment Agreement shall remain in full force and effect and are enforceable, to the
extent any such terms therein survive or govern the period after the Term of that Employment
Agreement. The event of revocation of this Separation and Release Agreement in accordance with
Section 8 herein in no way affects the validity or enforceability of the Employment Agreement; and
in the event of revocation, to the extent any pertinent terms of this Agreement reiterate or
confirm the terms of the Employment Agreement, the Employment Agreement shall govern.

9

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

          22. Entire Agreement. When read in conjunction with the Employment Agreement, this
Agreement constitutes the entire Agreement between the parties relating to EMPLOYEE’s separation
from and release of employment-related claims against THE COMPANY, and it shall not be modified
except in writing signed by the party to be bound. In the event of any conflict between this
Agreement and the Employment Agreement, this Agreement shall control.

          23. Severability. If a court finds any provision of this Agreement invalid or
unenforceable as applied to any circumstance, the remainder of this Agreement and the application
of such provision shall be interpreted so as best to effect the intent of the parties hereto. The
parties further agree to replace any such void or unenforceable provision of this Agreement with a
valid and enforceable provision that will achieve, to the extent possible, the economic, business,
or other purposes of the void or unenforceable provision.

          24. Governing Law and Jurisdiction. Notwithstanding any provision of the Employment
Agreement to the contrary, this Agreement shall be governed by the laws of the State of New Jersey
and any claims hereunder shall be pursued in the state or federal courts located in the State of
New Jersey.

          25. Survival of Terms. EMPLOYEE understands and agrees that the terms set out in this
Agreement, including the confidentiality, non-compete and non-solicitation provisions, shall
survive the signing of this Agreement and the receipt of benefits thereunder.

          26. Construction. The terms and language of this Agreement are the result of arm’s
length negotiations between both parties hereto and their attorneys. Consequently, there shall be
no presumption that any ambiguity in this Agreement should be resolved in favor of one party and
against another. Any controversy concerning the construction of this Agreement shall be decided
neutrally without regard to authorship.

          27. Copies. This Agreement may be executed in counterparts, and each counterpart,
when executed, shall have the efficacy of a signed original.

[SIGNATURE LINES CONTAINED ON NEXT PAGE]

10

 

CONFIDENTIAL INFORMATION OMITTED AND FILED SEPARATELY WITH 

SECURITIES AND EXCHANGE COMMISSION

ASTERISKS DENOTE SUCH OMISSION

     EMPLOYEE AGREES THAT: (1) HE HAS FULLY READ THIS AGREEMENT; (2) HE HAS TAKEN THE TIME
NECESSARY TO REVIEW COMPLETELY AND FULLY UNDERSTAND THIS AGREEMENT; AND (3) HE FULLY UNDERSTANDS
THIS AGREEMENT, ACCEPTS IT, AGREES TO IT, AND AGREES THAT IT IS FULLY BINDING UPON HIM FOR ALL
PURPOSES.

	 	 	 	 	 
	 	EMPLOYEE

 	 
	 	/s/ Scott L. Tarriff               12/25/2006
 	 
	 	SCOTT L. TARRIFF 	 
	 	 	 
	 
	 	PAR PHARMACEUTICAL COMPANIES, INC.

 	 
	 	/s/ Patrick LePore               1/4/07
 	 
	 	By: Patrick LePore 	 
	 	 	 
	 
	 	PAR PHARMACEUTICAL, INC.

 	 
	 	/s/ Patrick LePore               1/4/07
 	 
	 	By: Patrick LePore 	 
	 	 	 
	 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]